Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple sclerosis and the limits of classical autoimmune theory.

Frontiers in immunology·2026
Same author

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

The New England journal of medicine·2026
Same author

Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.

Annals of neurology·2026
Same author

Using EEG to Measure the Neural Effects of Oxytocin Administration: A Meta-Analysis and Systematic Review.

Psychophysiology·2026
Same author

Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).

Neurology·2026
Same author

Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

European journal of neurology·2026

Related Experiment Video

Updated: May 1, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.1K

Brain age in multiple sclerosis: a study with deep learning and traditional machine learning.

Lars Skattebøl1,2, Gro O Nygaard1, Esten H Leonardsen3,4

  • 1Department of Neurology, Oslo University Hospital, Oslo 0450, Norway.

Brain Communications
|May 8, 2025
PubMed
Summary
This summary is machine-generated.

Deep learning brain age estimation in multiple sclerosis shows stronger correlation with chronological age than traditional machine learning. Both AI methods link increased brain age to disability and disease duration, with deep learning potentially reducing scanner variability.

Keywords:
artificial intelligencebrain age gapmagnetic resonance imagingneurodegenerationscanner variability

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

907

Related Experiment Videos

Last Updated: May 1, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

907

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Neurodegenerative Diseases

Background:

  • Accelerated brain aging in multiple sclerosis (MS) correlates with disability.
  • Artificial intelligence (AI) offers tools for quantifying neurodegeneration.
  • Comparative data on traditional machine learning (ML) versus deep learning (DL) for brain age in MS is lacking.

Purpose of the Study:

  • To validate a deep learning (DL) brain age model in multiple sclerosis (MS).
  • To compare DL and traditional ML models for estimating brain age in MS.
  • To assess the association of brain age with clinical outcomes and scanner variability.

Main Methods:

  • Retrospective analysis of 4584 MRI scans from 1516 MS patients.
  • Comparison of a DL simple fully convolutional network with a traditional ML model for brain age estimation.
  • Analysis of clinical and MRI data from a longitudinal cohort using a uniform post-processing pipeline.

Main Results:

  • DL brain age estimates showed a stronger correlation with chronological age (r=0.90) than traditional ML (r=0.75).
  • Increased brain age, estimated by both methods, significantly correlated with disability (EDSS scores) and disease duration.
  • DL models demonstrated less scanner variability compared to traditional ML.

Conclusions:

  • Deep learning-derived brain age is a valid measure in MS, strongly associated with clinical disability.
  • DL brain age estimation performs comparably to traditional ML but may offer improved robustness against scanner differences.
  • AI-driven brain age assessment holds promise for monitoring neurodegeneration in MS.